Although the primary action of anti-VEGF therapy is thought to be rapid, early reduction in capillary endothelial membrane permeability [50, 76], changes in tumour Ktrans could also reflect post-treatment changes in regional capillary blood flow [71]. Here, VEGFA is linked to neoplasm.